Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1977 Jul;17(1):195-204.
doi: 10.1128/iai.17.1.195-204.1977.

Lung bacterial clearance in murine pneumococcal pneumonia

Lung bacterial clearance in murine pneumococcal pneumonia

M J Ansfield et al. Infect Immun. 1977 Jul.

Abstract

We studied the bactericidal capacity of the rat lung during the development of pneumococcal pneumonia. Pneumonia was produced in a lower lobe by the intrabronchial instillation of 10(4)Streptococcus pneumoniae cells in buffer. Lung bacterial counts progressively increased, reaching 10(7) per lung within 48 h, and the increase was associated with localized atelectasis and consolidation. Bacterial multiplication was inhibited with tetracycline at various intervals after infection, and the subsequent clearance of pneumococci was determined. Viable pneumococci were rapidly killed by lung defenses if bacterial multiplication was inhibited within 12 h of the onset of infection. No change occurred in the bacterial populationif tetracycline was delayed until 24 h after infection, indicating that pneumococcal killing by lung defenses had ceased. This effect could be reproduced with the addition of pneumococcal capsular polysaccharide to the inoculum, which produced a dose-related inhibition of pneumococcal clearance. The clearance of S. epidermidis was not impaired in the presence of pneumococcal pneumonia or by administration of exogenous capsular polysaccharide. These data indicate that pneumococcal pneumonia causes a marked impairment in lung antipneumococcal defenses within 24 h of the onset of infection. This acquired defect in antibacterial defenses may be due to the accumulation of pneumococcal capsular material in the lungs of infected animals.

PubMed Disclaimer

References

    1. Ann Intern Med. 1976 Mar;84(3):254-60 - PubMed
    1. J Clin Invest. 1976 Aug;58(2):271-5 - PubMed
    1. J Exp Med. 1956 Apr 1;103(4):499-508 - PubMed
    1. J Exp Med. 1956 Apr 1;103(4):509-22 - PubMed
    1. J Exp Med. 1964 Jan 1;119:167-76 - PubMed

Publication types

LinkOut - more resources